Home/Catalog/Aseptic Processing and Contamination Control Under EU GMP Annex 1: Practical Applications for Modern Sterile Operations
← Back to Catalog
Live WebinarNew

Aseptic Processing and Contamination Control Under EU GMP Annex 1: Practical Applications for Modern Sterile Operations

Learn how to apply EU GMP Annex 1 contamination control principles in practice — covering CCS, environmental monitoring signals, aseptic interventions, and sterility assurance decisions.

4.8(0 reviews)
1.5 hoursMonday, August 3, 2026
Meredith Crabtree

Instructor

Meredith Crabtree

GMP Quality Consultant & Validation Specialist

What You'll Learn

Understand sterility assurance expectations and Contamination Control Strategy (CCS) requirements under EU GMP Annex 1
Interpret environmental monitoring trends, excursions, and early risk signals before contamination events occur
Evaluate the impact of human interventions on critical aseptic operations and how to manage them
Apply CCS principles to real manufacturing and operational decisions in sterile environments
Manage contamination events, investigations, and escalation decisions effectively
Implement corrective actions that address root causes rather than just immediate symptoms
Build the evidence base supporting sterility assurance through environmental monitoring and CCS
Understand regulatory expectations for risk-based contamination control under Annex 1

About This Event

Aseptic processing operations continue to face increasing scrutiny as regulators place greater emphasis on contamination control, sterility assurance, intervention management, environmental monitoring, and the effectiveness of Contamination Control Strategies (CCS) under EU GMP Annex 1. While many organizations have updated procedures and implemented Annex 1 requirements, significant challenges often remain in translating regulatory expectations into practical operational decisions. Questions frequently arise around how contamination risks are evaluated, how interventions are managed, how monitoring data is interpreted, and whether existing controls genuinely support sterility assurance. This session examines the practical application of Annex 1 principles within modern sterile manufacturing environments. The discussion will focus on the operational decisions that influence contamination control effectiveness, the interpretation of environmental and process signals, the management of aseptic risks, and the rationale behind critical quality decisions. Real-world examples will be used to explore how organizations can strengthen contamination control programs while maintaining practical and sustainable sterile operations. WHY YOU SHOULD ATTEND In sterile manufacturing, few decisions are made with complete information. Environmental monitoring results may appear inconclusive. Interventions may seem routine. Minor deviations may appear isolated. Yet many contamination investigations reveal that warning signs were present long before the event itself was recognized. Teams operating under EU GMP Annex 1 are increasingly expected to recognize and act upon those signals before contamination events, sterility concerns, or adverse trends become fully apparent. Annex 1 places increasing emphasis on contamination control as an active process supported by an effective CCS rather than a collection of independent procedures. This requires organizations to evaluate risks continuously, interpret signals appropriately, and justify actions taken when certainty does not yet exist. This session focuses on the judgment, rationale, and decision-making that support effective contamination control within modern sterile operations and help organizations maintain confidence in sterility assurance. Code: FDB1613

Curriculum

Sterility Assurance Expectations Under EU GMP Annex 1
12 min
Contamination Control Strategy (CCS): From Document to Active Process
10 min
Applying CCS Principles to Real Manufacturing Decisions
10 min

Requirements

  • Working in sterile manufacturing, aseptic processing, or biopharmaceutical operations
  • Applicable to quality, microbiology, validation, manufacturing, and regulatory affairs professionals
  • Relevant to organizations implementing or strengthening EU GMP Annex 1 compliance programs

Who Should Attend

This session is designed for professionals working in sterile manufacturing and aseptic processing environments subject to EU GMP Annex 1. Essential for: Quality Assurance (QA), Sterile Manufacturing and Operations, Microbiology and Environmental Monitoring Personnel, Validation and Qualification Professionals, Quality Control (QC), Manufacturing Science and Technical Services (MS&T), Compliance and Quality Systems Professionals, and Regulatory Affairs and Sterile Product Leadership.

Areas Covered

Sterility Assurance Expectations Under EU GMP Annex 1
Environmental Monitoring Trends, Excursions, and Early Risk Signals
Human Interventions and Their Impact on Critical Aseptic Operations
Applying CCS Principles to Real Manufacturing and Operational Decisions
Contamination Events, Investigations, and Escalation Decisions
Corrective Actions That Address Root Causes Rather Than Immediate Symptoms
Environmental Monitoring, CCS, and the Evidence Supporting Sterility Assurance
Regulatory Expectations for Risk-Based Contamination Control Under Annex 1

Meet Your Instructor

Meredith Crabtree

Meredith Crabtree

GMP Quality Consultant & Validation Specialist

Meredith Crabtree has over 30 years' experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting and specializes in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.

30+ Years GMP ExperienceIQ/OQ/PQ SpecialistConsent Decree SupportMulti-Industry QA Expert
Quantity
1

Single Access

$240.00
Buy Now
Secure payment via Stripe
Certificate of completion

Event Details

Format

Live Webinar

Duration

1.5 hours

Certificate

Included

Date

Monday, August 3, 2026

Related Events

AI in GMP: What the FDA Is Already Expecting - Before You Ask
Live WebinarNew-24%
Regulatory & ComplianceCertificate

AI in GMP: What the FDA Is Already Expecting - Before You Ask

FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.

Dr. Ginette CollazoDr. Ginette Collazo
1.5 hoursJun 30, 2026
4.8
$190.00$250.00
View Details
HPLC Analytical Method Development and Validation
Live WebinarNew
Regulatory & ComplianceCertificate

HPLC Analytical Method Development and Validation

Master HPLC instrument and method validation to meet US EPA and FDA requirements for pharmaceutical analysis.

Dr. John C. FetzerDr. John C. Fetzer
1 hourJun 17, 2026
4.8
$145.00
View Details
ChatGPT-Assisted Technical Writing
Live WebinarNew
Regulatory & ComplianceCertificate

ChatGPT-Assisted Technical Writing

Learn practical, compliant approaches to using ChatGPT for SOP drafting, document development, and technical writing in regulated industries.

Charles H. PaulCharles H. Paul
1 hourJun 24, 2026
4.9
$190.00
View Details